• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结节性硬化症相关神经精神障碍:儿科队列研究。

Tuberous sclerosis-associated neuropsychiatric disorders: a paediatric cohort study.

机构信息

Department of Women's and Children's Health, University Hospital of Padua, Padua, Italy.

Department of Developmental Psychology and Socialization, University of Padua, Padua, Italy.

出版信息

Dev Med Child Neurol. 2019 Feb;61(2):168-173. doi: 10.1111/dmcn.14055. Epub 2018 Oct 9.

DOI:10.1111/dmcn.14055
PMID:30298907
Abstract

AIM

We aimed to study tuberous sclerosis-associated neuropsychiatric disorders (TAND) in children and adolescents with tuberous sclerosis complex (TSC).

METHOD

Retrospective and prospective cohort study conducted at a Paediatric Neurology Unit of an Italian Tertiary Care Hospital. Clinical and neuroimaging data were reviewed. Scores for neurological and epilepsy outcomes (Extended Glasgow Outcome Scale, Paediatric Version and Early Childhood Epilepsy Severity Scale modified), semi-structured interviews (authorized Italian version of the TAND checklist and Vineland Adaptive Behavior Scales) and questionnaires (Child Behavior Checklist [CBCL]) were applied at last follow-up.

RESULTS

Thirty-two patients with TSC (age range 1-19y) were enrolled. Eighty-eight per cent had at least one TAND and 47% had intellectual disability. The TAND checklist showed internalizing problems in 25.8% of cases (vs 41.9% by CBCL), and externalizing problems in 41.9% (vs 9.7% by CBCL). TAND prevailed in patients with de novo mutation of TSC2, high tuber load, and severe neurological and epilepsy outcomes.

INTERPRETATION

In our cohort, 78% of patients had more than four TAND behavioural problems; nevertheless, they did not show a constant and specific neuropsychiatric profile. Clinical, neurophysiological, and neuroradiological features were associated with several TAND. The TAND checklist appeared more effective than the CBCL, particularly in detecting externalizing problems.

WHAT THIS PAPER ADDS

The Tuberous sclerosis-associated neuropsychiatric disorders (TAND) checklist is an effective tool for TAND screening. The TAND checklist helps define psychopathological and neuropsychiatric aspects in paediatric patients with Tuberous sclerosis complex (TSC). TAND were found in 88% of patients with TSC, whilst 78% had more than four TAND. TAND distribution depends on different clinical and neuroradiological features.

摘要

目的

我们旨在研究结节性硬化症相关神经精神障碍(TAND)在结节性硬化症患儿中的表现。

方法

这是在意大利一家三级保健医院的儿科神经病学单位进行的回顾性和前瞻性队列研究。回顾了临床和神经影像学数据。在最后一次随访时应用了神经和癫痫结局评分(扩展格拉斯哥结局量表,儿科版和早期儿童癫痫严重程度量表修订版)、半结构化访谈(TAND 检查表和韦氏儿童智力量表的授权意大利语版本)和问卷(儿童行为检查表[CBCL])。

结果

共纳入 32 例 TSC 患儿(年龄 1-19 岁)。88%的患儿至少有一种 TAND,47%的患儿存在智力障碍。TAND 检查表显示有 25.8%的病例存在内化问题(CBCL 为 41.9%),41.9%的病例存在外化问题(CBCL 为 9.7%)。在 TSC2 基因突变、高结节负荷、严重神经和癫痫结局的患者中,TAND 更为常见。

结论

在我们的队列中,78%的患者有超过四种 TAND 行为问题;然而,他们并没有表现出一种恒定而特异的神经精神特征。临床、神经生理学和神经影像学特征与多种 TAND 相关。TAND 检查表比 CBCL 更有效,特别是在检测外化问题方面。

这篇论文的重要性

Tuberous sclerosis-associated neuropsychiatric disorders(TAND)检查表是一种有效的 TAND 筛查工具。TAND 检查表有助于确定小儿结节性硬化症患者的精神病理学和神经心理学方面。在 TSC 患儿中,88%存在 TAND,78%存在超过四种 TAND。TAND 的分布取决于不同的临床和神经影像学特征。

相似文献

1
Tuberous sclerosis-associated neuropsychiatric disorders: a paediatric cohort study.结节性硬化症相关神经精神障碍:儿科队列研究。
Dev Med Child Neurol. 2019 Feb;61(2):168-173. doi: 10.1111/dmcn.14055. Epub 2018 Oct 9.
2
Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders and Parental Stress: Findings from a National, Prospective TSC Surveillance Study.结节性硬化症相关神经精神障碍与父母压力:一项全国性前瞻性结节性硬化症监测研究的结果
Neuropediatrics. 2019 Oct;50(5):294-299. doi: 10.1055/s-0039-1693042. Epub 2019 Jul 2.
3
The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1.TAND 清单:一种用于结节性硬化症和神经纤维瘤病 1 型患儿的有用筛查工具。
Orphanet J Rare Dis. 2020 Sep 7;15(1):237. doi: 10.1186/s13023-020-01488-4.
4
Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist.结节性硬化症相关神经精神障碍(TAND)及TAND检查表
Pediatr Neurol. 2015 Jan;52(1):25-35. doi: 10.1016/j.pediatrneurol.2014.10.004. Epub 2014 Oct 16.
5
Neuropsychiatric comorbidities in tuberous sclerosis complex patients with epilepsy: results of the TAND checklist survey.结节性硬化症合并癫痫患者的神经精神共病:TAND检查表调查结果
Acta Neurol Belg. 2024 Jun;124(3):973-979. doi: 10.1007/s13760-024-02510-3. Epub 2024 Mar 25.
6
[Neuropsychiatric manifestations in Tuberous Sclerosis Complex (TSC): diagnostic guidelines, TAND concept and therapy with mTOR inhibitors].[结节性硬化症(TSC)的神经精神表现:诊断指南、TAND概念及mTOR抑制剂治疗]
Z Kinder Jugendpsychiatr Psychother. 2019 Mar;47(2):139-153. doi: 10.1024/1422-4917/a000604. Epub 2018 Aug 6.
7
Measurement of Developmental and Behavioral Concerns in Toddlers With Tuberous Sclerosis Complex.评估结节性硬化症幼儿的发育和行为问题。
Pediatr Neurol. 2024 Jun;155:62-67. doi: 10.1016/j.pediatrneurol.2024.03.014. Epub 2024 Mar 22.
8
Pilot validation of the tuberous sclerosis-associated neuropsychiatric disorders (TAND) checklist.结节性硬化症相关神经精神障碍(TAND)检查表的初步验证
Pediatr Neurol. 2015 Jan;52(1):16-24. doi: 10.1016/j.pediatrneurol.2014.10.006. Epub 2014 Oct 16.
9
Seizure freedom but not epilepsy surgery is associated with fewer neuropsychiatric difficulties in patients with tuberous sclerosis.癫痫发作自由而非癫痫手术与结节性硬化症患者的神经精神问题减少相关。
Epilepsy Behav. 2024 Aug;157:109875. doi: 10.1016/j.yebeh.2024.109875. Epub 2024 Jun 1.
10
TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study.结节性硬化症相关神经精神障碍(TAND):来自 TOSCA 自然史研究的结果。
Orphanet J Rare Dis. 2018 Sep 10;13(1):157. doi: 10.1186/s13023-018-0901-8.

引用本文的文献

1
Protocol for EpiCom: A phase 3b/4 study of behavioral outcomes following adjunctive cannabidiol for the management of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).EpiCom研究方案:一项关于辅助使用大麻二酚治疗结节性硬化症相关神经精神障碍(TAND)后行为结果的3b/4期研究。
PLoS One. 2025 Jun 12;20(6):e0324648. doi: 10.1371/journal.pone.0324648. eCollection 2025.
2
Towards the phenotyping of autism spectrum disorder in children with tuberous sclerosis complex.结节性硬化症患儿自闭症谱系障碍的表型分析
Dev Med Child Neurol. 2025 Sep;67(9):1113-1114. doi: 10.1111/dmcn.16328. Epub 2025 Apr 14.
3
Deep developmental phenotyping in children with tuberous sclerosis complex, with and without autism.
结节性硬化症合并或不合并自闭症儿童的深度发育表型分析
Dev Med Child Neurol. 2025 Sep;67(9):1165-1175. doi: 10.1111/dmcn.16293. Epub 2025 Mar 7.
4
Neuropsychiatric profile in tuberous sclerosis complex patients with epilepsy.结节性硬化症合并癫痫患者的神经精神概况
Front Pediatr. 2025 Jan 15;12:1436061. doi: 10.3389/fped.2024.1436061. eCollection 2024.
5
Central nervous system manifestations of tuberous sclerosis complex: A single centre experience in Qatar.结节性硬化症的中枢神经系统表现:卡塔尔的单一中心经验。
Saudi Med J. 2024 Nov;45(11):1245-1252. doi: 10.15537/smj.2024.45.11.20240444.
6
Review of the spectrum of tuberous sclerosis complex: The Saudi Arabian Experience.《结节性硬化症谱的回顾:沙特阿拉伯的经验》。
Neurosciences (Riyadh). 2024 May;29(2):113-121. doi: 10.17712/nsj.2024.2.20230061.
7
Behavioral and Psychiatric Disorders in Syndromic Autism.综合征性自闭症中的行为和精神障碍
Brain Sci. 2024 Mar 30;14(4):343. doi: 10.3390/brainsci14040343.
8
Neuropsychiatric comorbidities in tuberous sclerosis complex patients with epilepsy: results of the TAND checklist survey.结节性硬化症合并癫痫患者的神经精神共病:TAND检查表调查结果
Acta Neurol Belg. 2024 Jun;124(3):973-979. doi: 10.1007/s13760-024-02510-3. Epub 2024 Mar 25.
9
Development and Feasibility of the Self-Report Quantified Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders Checklist (TAND-SQ).《自报告型结节性硬化症相关神经精神障碍检查表(TAND-SQ)的编制与可行性研究》。
Pediatr Neurol. 2023 Oct;147:101-123. doi: 10.1016/j.pediatrneurol.2023.07.001. Epub 2023 Jul 7.
10
De novo mutation of the TSC2 gene in patient with Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders (TAND) Phenotype: a case report.结节性硬化症相关神经精神障碍(TAND)表型患者中TSC2基因的新发突变:一例报告
Ann Med Surg (Lond). 2023 Apr 3;85(5):2102-2107. doi: 10.1097/MS9.0000000000000489. eCollection 2023 May.